Get started

Cypher-harmonic

$MDJH Next Target PT 3.90 and higherMDJM Ltd, through its subsidiaries and variable interest entity, operates as an integrated real estate services company in the People's Republic of China. It offers real estate agency services to real estate developers; and real estate consulting services, such as consulting, marketing strategy planning and strategy, and advertising services and sales strategies. The company also provides independent training and tourism development services. It serves real estate developers, real estate design institutes and agencies, urban planning bureaus of various levels of governments, and urban rail transportation companies, as well as urban infrastructure development companies. The company was formerly known as MDJLEAD LTD. and changed its name to MDJM Ltd. in May 2018. MDJM Ltd was founded in 2002 and is headquartered in Tianjin, the People's Republic of China.
NASDAQ:MDJHLong
by BADQOMOCAWGOWLD
$NAK Next Target PT .58 and not higherNorthern Dynasty Minerals Ltd. engages in the exploration of mineral properties in the United States. Its principal mineral property is the Pebble copper-gold-molybdenum project comprising 2,402 mineral claims that covers an area of approximately 417 square miles located in southwest Alaska. The company was formerly known as Northern Dynasty Explorations Ltd. and changed its name to Northern Dynasty Minerals Ltd. in October 1997. Northern Dynasty Minerals Ltd. was incorporated in 1983 and is headquartered in Vancouver, Canada.
AMEX:NAKLong
by BADQOMOCAWGOWLD
$GLG Next Target PTs .50-.75 Long term PT 2.25 and higherTD Holdings, Inc. engages in commodities trading and supply chain service businesses in China. Its commodity trading business engages in purchasing non-ferrous metal products, such as aluminium ingots, copper, silver, and gold, from upstream metal and mineral suppliers and then selling to downstream customers. The company's supply chain service business covers a range of commodities, including non-ferrous metals, ferrous metals, coal, metallurgical raw materials, soybean oils, oils, rubber, wood, and various other types of commodities. It serves as a one-stop commodity supply chain service and digital intelligence supply chain platform integrating upstream and downstream enterprises, warehouses, logistics, information, and futures trading. TD Holdings, Inc. has a strategic agreement with Guangzhou Wensheng Blockchain Technology Co. Ltd. to apply blockchain technology in the supply chain financing and development of cloud-based warehouse. The company was formerly known as Bat Group, Inc. and changed its name to TD Holdings, Inc. in March 2020. TD Holdings, Inc. was incorporated in 2011 and is based in Beijing, the People's Republic of China.
GLong
by BADQOMOCAWGOWLD
$AVCT SUPPORT AND RESISTANCE$AVCT: SI 14% | BC 150% SUPPORT AND RESISTANCE BULLISH CYPHER American Virtual Cloud Technologies, Inc. provides IT solutions and managed services. It offers managed IT services to a range of clients, including unified communications-as-a-service, directory and messaging, enterprise networking, cybersecurity, collaboration, data center, integration, storage, backup, virtualization, and converged infrastructure. The company was founded in 1987 and is based in Atlanta, Georgia.
ALong
by BADQOMOCAWGOWLD
2
$CPIXCumberland Pharmaceuticals shares are trading higher after the company announced the FDA approved expanded labeling for Caldolor to now include use in pre-operative administration. Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and rheumatology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative, for the treatment of chronic and acute constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol injection for treating euvolemic and hypervolemic hyponatremia; and Vibativ injection, for the treatment of certain serious bacterial infections. It also develops RediTrex injection for the treatment of active rheumatoid, juvenile idiopathic, and severe psoriatic arthritis, as well as disabling psoriasis. The company markets and sells its products through sales representatives and district managers. In addition, the company is developing ifetroban, a product candidate that is in phase II clinical trial for the treatment of aspirin-exacerbated respiratory disease, systemic sclerosis, and duchenne muscular dystrophy; and has completed phase II clinical trial for the treatment of hepatorenal syndrome and portal hypertension. Cumberland Pharmaceuticals Inc. was incorporated in 1999 and is headquartered in Nashville, Tennessee.
NASDAQ:CPIXLong
by BADQOMOCAWGOWLD
Falling Wedge - Gap Fill- BullishUPST starting to look really interesting after seemingly finding a bottom after selling off post-earnings leaving a big gap to fill on the upside. Big falling wedge on the 4-hour timeframe along with a bullish cypher, RSI is also way in oversold territory. Bollinger bands are squeezing on shorter timeframes and buyer volume picking up. Bullish will be looking for a breakout from this wedge & for UPST to go for the gap fill on the upside (Broader Market Conditions Permitting)- Just some support and resistance levels to keep an eye on along with some RSI-based supply and demand zones in the meantime - Falling Wedge - Gap on the Upside to Fill - RSI Oversold - MACD Cross - Bullish Cypher Formed - Bollinger Bands Squeezing on the Hourly Timeframe PT1- $220.25 PT2- $225.94 PT3- $228.04 PT4- $256.38 + Gap Fill
NASDAQ:UPSTLong
by jacobosiason7
1
$FLOKIUSDT Cypher PatternFloki Inu Coin Price & Market Data Floki Inu price today is $0.00023525 with a 24-hour trading volume of $34,127,064. FLOKI price is down -8.9% in the last 24 hours. It has a circulating supply of 0 FLOKI coins and a total supply of 10 Trillion. If you are looking to buy or sell Floki Inu, PancakeSwap (v2) is currently the most active exchange. Floki is the name Elon Musk wishes to give to his future pet Shiba. Floki Inu has a token burn of 1% each transaction, transaction fees of 5%, and a transaction redistribution to holders of 5%.
Long
by BADQOMOCAWGOWLD
1
$EFTR SAN DIEGO, Sept. 16, 2021 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics (NASDAQ: EFTR), a leader in the development of selective translation regulator inhibitors (STRIs) for the treatment of cancer, today announced that company management will participate in a fireside chat at the 2021 Cantor Virtual Global Healthcare Conference at 2:40 p.m. ET on Tuesday, September 28, 2021. eFFECTOR will also host investor meetings throughout the conference. A live webcast of the fireside chat will be available on the "Events and Presentation" page of the Investors section of the Company’s website. A replay of the webcast will be available for 30 days following the event. For more information, please visit investors.effector.com. About eFFECTOR Therapeutics eFFECTOR is a clinical-stage biopharmaceutical company focused on pioneering the development of a new class of oncology drugs referred to as STRIs. eFFECTOR’s STRI product candidates target the eIF4F complex and its activating kinase, mitogen-activated protein kinase interacting kinase (MNK). The eIF4F complex is a central node where two of the most frequently mutated signaling pathways in cancer, the PI3K-AKT and RAS-MEK pathways, converge to activate the translation of select mRNA into proteins that are frequent culprits in key disease-driving processes. Each of eFFECTOR’s product candidates is designed to act on a single protein that drives the expression of multiple functionally related proteins, including oncoproteins and immunosuppressive proteins in T cells, that together control tumor growth, survival and immune evasion. eFFECTOR’s lead product candidate, tomivosertib, is a MNK inhibitor currently being evaluated in KICKSTART, a randomized, double-blind, placebo-controlled Phase 2b trial of tomivosertib in combination with pembrolizumab in patients with metastatic non-small cell lung cancer (NSCLC). Zotatifin, eFFECTOR’s inhibitor of eIF4A, is currently being evaluated in Phase 2a expansion cohorts in certain biomarker-positive solid tumors, including ER+ breast cancer and KRAS-mutant NSCLC. eFFECTOR has a global collaboration with Pfizer to develop inhibitors of a third target, eIF4E. In addition to the company’s oncology focus, zotatifin is being evaluated as a potential host-directed anti-viral therapy in patients with mild to moderate COVID-19 in collaboration with the University of California, San Francisco, under a $5 million grant sponsored by the Defense Advanced Research Projects Agency. eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors (STRIs) for the treatment of cancer. Its lead product candidate is Tomivosertib, an oral small-molecule inhibitor of MNK1/2 that is in phase 2b clinical trial for the treatment of patients with metastatic non-small cell lung cancer (NSCLC). The company is also developing Zotatifin, a small molecule designed to inhibit eukaryotic initiation factor 4A (eIF4E), which is in phase 1/2 clinical trial to treat patients with solid tumors. It has a collaboration agreement with Pfizer Inc. to develop inhibitors of eIF4E. The company was founded in 2012 and is headquartered in San Diego, California.
ELong
by BADQOMOCAWGOWLD
Comparison charts: $HLBZ $IRNTHelbiz Inc. provides micro-mobility services. The company offers a fleet of vehicles, including e-scooters, e-bicycles, and e-mopeds all on one convenient platform in 35 cities worldwide. It utilizes a customized, proprietary fleet management platform, artificial intelligence, and environmental mapping to optimize operations and business sustainability. The company also focuses on expanding its urban lifestyle products and services to include live streaming services, food delivery, financial services, and others accessible within its mobile app. The company was incorporated in 2015 and is headquartered in New York, New York. IronNet Cybersecurity, Inc. designs and develops solutions for cyber-attacks. It offers IronDefense, a network traffic analysis platform that delivers scalable behavioral analysis and integrated packet-level cyber hunt to detect advanced threats; and IronDome, a collective defense solution that delivers machine-speed visibility of potential threat campaigns targeting participant industry peers. The company also provides a suite of technologies that provide real-time threat assessment and updates, behavioral modeling, big data analytics, and proactive responses; and consulting and training programs to protect against current and emerging threats. Its security solutions include collective defense, network traffic analysis, and cyber assessment tools. The company serves energy and utilities, financial services, healthcare and life sciences, defense, and public sector industries. The company was incorporated in 2014 and is based in McLean, Virginia with additional offices in Raleigh, North Carolina; Fulton, Maryland; London, United Kingdom; and Singapore.
HLong
by BADQOMOCAWGOWLD